Covered recipient · General Payments record
CLAUDIO OSORIO
Allopathic & Osteopathic Physicians Psychiatry & Neurology Epilepsy
General Payments · PY2020–2024
$8,443.15
- Reported across 271 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $504.70 | 12 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $143.60 | 5 |
| Teva Pharmaceuticals USA, Inc. | $118.24 | 1 |
| Neurelis, Inc. | $111.27 | 1 |
| LivaNova USA, Inc. | $28.59 | 1 |
| CATALYST PHARMACEUTICALS, INC. | $27.88 | 1 |
| Neurocrine BioSciences, Inc. | $26.10 | 1 |
| JAZZ PHARMACEUTICALS INC. | $25.88 | 1 |
| ARGENX US, INC. | $23.14 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $31.18 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105161237 | CMS |
| ABBVIE INC. | $32.55 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105161239 | CMS |
| ABBVIE INC. | $33.61 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105161241 | CMS |
| ABBVIE INC. | $25.21 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105161243 | CMS |
| ABBVIE INC. | $21.05 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105161245 | CMS |
| ARGENX US, INC. | $23.14 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142128112 | CMS |
| CATALYST PHARMACEUTICALS, INC. | $27.88 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144459663 | CMS |
| JAZZ PHARMACEUTICALS INC. | $25.88 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150230809 | CMS |
| LivaNova USA, Inc. | $28.59 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152799225 | CMS |
| Neurelis, Inc. | $111.27 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145649926 | CMS |
| Neurocrine Biosciences, Inc. | $26.10 | 12/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150836732 | CMS |
| Teva Pharmaceuticals USA, Inc. | $118.24 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151704597 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.